Entresto 24 MG-26 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FKUDD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,613
Award facts
- Contract value 100% obligated
- $19,612.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count) with a ceiling value of $19,612.74. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The order is scheduled for ultimate completion by July 30, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's extensive portfolio with the Defense Logistics Agency encompasses a wide range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains. Entresto, a cardiovascular medication used in heart failure treatment, represents a typical specialty pharmaceutical product within the company's federal medical supply offerings. AmerisourceBergen's DLA prime contract serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, providing comprehensive global pharmaceutical support to military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FKUDD?
SPE2DB25FKUDD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FKUDD worth?
The government has obligated $19,613 on SPE2DB25FKUDD.
Is contract SPE2DB25FKUDD an order under another contract?
Yes. SPE2DB25FKUDD is a delivery order under SPE2DB24D3014, an indefinite delivery contract.
Was contract SPE2DB25FKUDD competed?
The extent of competition for SPE2DB25FKUDD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award